Got the distinct feeling that webinar was for the potential partners watching. Great detail provided by Donna and Mukesh. 008 really has corralled some compelling clinical data now that is going to be very very hard for interested parties to just walk away from. 008 always existed to ramp up the DMOAD data to inform partnership discussions (and TGA provisional approval applications) and boy, has it delivered. They may even come out of it with a pathway to DMOAD on the label from the FDA after Para_002. What a result that would be.
- Forums
- ASX - By Stock
- PAR
- Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-68
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M |
Open | High | Low | Value | Volume |
22.5¢ | 23.5¢ | 22.0¢ | $65.40K | 290.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 96390 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 138166 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 91390 | 0.220 |
6 | 88958 | 0.215 |
5 | 131050 | 0.210 |
4 | 104982 | 0.205 |
6 | 184175 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 138166 | 5 |
0.240 | 40833 | 1 |
0.250 | 15000 | 1 |
0.255 | 9785 | 1 |
0.260 | 26050 | 3 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online